A Randomised, Placebo Controlled, Double-Blinded Comparative Study Evaluating the Effect of Ramipril on Urinary Protein Excretion in Maintenance Renal Translplant Patients Converted to Sirolimus

Trial Profile

A Randomised, Placebo Controlled, Double-Blinded Comparative Study Evaluating the Effect of Ramipril on Urinary Protein Excretion in Maintenance Renal Translplant Patients Converted to Sirolimus

Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Oct 2014

At a glance

  • Drugs Ramipril (Primary) ; Sirolimus
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 01 Sep 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 30 Mar 2013 Planned number of patients changed from 440 to 457 as reported by European Clinical Trials Database.
    • 02 Jun 2012 Additional locations added as reported by European Clinical Trials Database record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top